Proactive - Interviews for investors: ImmuPharma CEO Tim McCarthy shares latest developments with P140 platform, road ahead
Update: 2025-01-24
Description
ImmuPharma PLC (AIM:IMM) CEO Tim McCarthy joined Stephen Gunnion in the Proactive studio to discuss the company’s recent groundbreaking developments in autoimmune disease treatment. He highlighted the progress made with their P140 platform, emphasising its potential to address multiple autoimmune diseases and transform patient care.
McCarthy explained, “This is a breakthrough in a lot of different ways,” referencing recent preclinical findings that allow the identification and categorisation of autoimmune diseases, paving the way for personalised medicine. He also noted the significant interest in P140 from major pharmaceutical companies, underlining its potential to deliver effective treatment without adverse effects.
Additionally, McCarthy shared updates from the JP Morgan and Biotech Showcase conferences, where these advancements were presented to key industry players. ImmuPharma’s focus in 2025 includes expanding its partnerships and delivering on its transformative pipeline.
Stay tuned for more updates on ImmuPharma’s innovations in the biotech space. Visit Proactive’s YouTube channel for more videos, and don’t forget to like, subscribe, and turn on notifications for future content.
#ImmuPharma #AutoimmuneDiseases #P140Platform #PersonalizedMedicine #Biotech #TimMcCarthy #PharmaceuticalInnovation #LupusTreatment #CIDP #HealthcareRevolution
McCarthy explained, “This is a breakthrough in a lot of different ways,” referencing recent preclinical findings that allow the identification and categorisation of autoimmune diseases, paving the way for personalised medicine. He also noted the significant interest in P140 from major pharmaceutical companies, underlining its potential to deliver effective treatment without adverse effects.
Additionally, McCarthy shared updates from the JP Morgan and Biotech Showcase conferences, where these advancements were presented to key industry players. ImmuPharma’s focus in 2025 includes expanding its partnerships and delivering on its transformative pipeline.
Stay tuned for more updates on ImmuPharma’s innovations in the biotech space. Visit Proactive’s YouTube channel for more videos, and don’t forget to like, subscribe, and turn on notifications for future content.
#ImmuPharma #AutoimmuneDiseases #P140Platform #PersonalizedMedicine #Biotech #TimMcCarthy #PharmaceuticalInnovation #LupusTreatment #CIDP #HealthcareRevolution
Episode: https://proactive-interviews-for-investors.simplecast.com/episodes/20250123-immupharma-plc-4tMEh_SK
Podcast: https://proactive-interviews-for-investors.simplecast.com
Comments
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
